Related Funds
Fund Name | Location |
BankInvest Biomedical Venture | - |
Bluefield Investments | England, London, United Kingdom |
Chaotic Investments | California, Los Angeles, United States |
CIT Healthcare Finance | - |
Davidson Capital Group | Florida, Santa Rosa Beach, United States |
Divergent Ventures | Seattle, United States, Washington |
FedDev | Canada, Ontario, Waterloo |
Femmes Business Angels | France, Ile-de-France, Paris |
Fullcent Capital | Beijing, Beijing, China |
Fushia Investments | - |
Gerako | Espoo, Finland, Uusimaa |
Honest Ventures | - |
Paramount BioCapital Asset Management | New York, New York, United States |
Polymath Capital | California, San Francisco, United States |
Shanghai Decun Touzi Youxian Gongsi | China, Shanghai |
Tangel Publishing | Changsha, China, Jiangsu |
UCAL Fuel Systems | Chennai, India, Tamil Nadu |
Wellborn Ventures | Israel, Tel Aviv, Tel Aviv District |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ECARX | $200M | 25 Feb 2021 | Shangcheng District, Zhejiang, China | ||
Honyar | $1M | 05 Feb 2013 | Shangcheng District, Zhejiang, China | ||
Honyar | $463K | 13 May 2005 | Shangcheng District, Zhejiang, China | ||
Zhongce Che Kongjian | $463K | 09 Oct 2003 | China, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ECARX | $200M | 25 Feb 2021 | Shangcheng District, Zhejiang, China | ||
Honyar | $1M | 05 Feb 2013 | Shangcheng District, Zhejiang, China | ||
Honyar | $463K | 13 May 2005 | Shangcheng District, Zhejiang, China | ||
Zhongce Che Kongjian | $463K | 09 Oct 2003 | China, Zhejiang |